Finsbury Worldwide Pharm Tst PLC
03 August 2006
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
3 AUGUST 2006
Exercise of Warrants
Finsbury Worldwide Pharmaceutical Trust PLC (the 'Company') announces that
following receipt of notices to exercise Warrants at an exercise price of 464p
on the exercise date of 31 July 2006, the Company has allotted and issued as
fully paid 32,731 new Ordinary shares in the Company under the General Block
Listing.
Following allotment, the issued share capital of the Company will be 57,604,881
Ordinary shares and 10,773,367 Warrants.
The outstanding Warrants are exercisable on 31 July* in each of the years 2007
to 2009 inclusive at an exercise price of 464p. Warrant Exercise Notices shall
be sent to all Warrant holders prior to commencement of the exercise period of
28 days prior to each exercise date.
As at the close of 31 July 2006, the fully diluted Net Asset Value per Ordinary
share was 500.03p per share, the mid market share price per Ordinary share was
486.50p and the mid market Warrant price was 115.20p.
*or if such day is not a business day, then on the next business day
- Ends -
For further information, please contact:
Tracey Lago Close Finsbury Asset Management Limited 020 7426 6219
Alastair Smith Close Finsbury Asset Management Limited 020 7426 6240
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.